Loading...
Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment
The nonvitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), dabigatran, apixaban, edoxaban, and rivaroxaban, have emerged as effective alternatives to vitamin K antagonists (VKAs) across several indications, including the prevention of stroke and...
Na minha lista:
| Udgivet i: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5562140/ https://ncbi.nlm.nih.gov/pubmed/28651452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944717714921 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|